The tumour suppressor protein LIMD1 is a novel regulator of HIF1 and the hypoxic response

There are three prolyl hydroxylases (PHD1, 2 and 3) that regulate the hypoxia-inducible factors (HIFs), the master transcriptional regulators that respond to changes in intracellular O2 tension. In high O2 tension (normoxia) the PHDs hydroxylate HIFα subunits on 2 conserved proline residues inducing...

Full description

Bibliographic Details
Main Author: Webb, Thomas M.
Published: University of Nottingham 2010
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.523477
id ndltd-bl.uk-oai-ethos.bl.uk-523477
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-5234772016-10-04T03:21:46ZThe tumour suppressor protein LIMD1 is a novel regulator of HIF1 and the hypoxic responseWebb, Thomas M.2010There are three prolyl hydroxylases (PHD1, 2 and 3) that regulate the hypoxia-inducible factors (HIFs), the master transcriptional regulators that respond to changes in intracellular O2 tension. In high O2 tension (normoxia) the PHDs hydroxylate HIFα subunits on 2 conserved proline residues inducing binding of the von-Hippel-Lindau (VHL) tumour suppressor, the recognition component of a multi-protein ubiquitin-ligase complex, initiating HIFα ubiquitylation and degradation by the 26S proteasome. However, it is not known whether PHDs and VHL act separately to exert their enzymatic activities on HIFα or as a multi-protein complex. In this thesis, data are presented that shows that the tumour suppressor protein LIMD1 acts as a molecular scaffold simultaneously binding the PHDs and pVHL into a normoxic protein complex (normoxiplex), increasing their physical proximity in order to enable efficient and rapid sequential modifications and thus degradation of HIF1α. Data are presented which indicates that increased LIMD1 expression down regulates HIF transcriptional activity, by promoting HIF1α degradation via the oxygen dependent degradation domain in a manner dependent on hydroxylase and 26S proteasome activities. However, degradation of this domain is not wholly dependent on the well characterised proline residues subject to hydroxylation, suggesting that LIMD1 may alter proline hydroxylation specificity or modulate HIF via a different mechanism. Furthermore, endogenous depletion of LIMD1 results in the converse, leading to HIF1α stabilisation and accumulation, enhancing HIF transcriptional activity. Moreover, Limd1-/- MEFs show increased HIF transcriptional activity. One mechanism by which this is achieved involves the binding of PHD2 within the N-terminal portion of LIMD1 while allowing concurrent binding of VHL to the C-terminal zinc-finger LIM domains. However, the LIMD1 mediated mechanism regulating HIF1α independently of proline residues 402 and 564 is still unclear. Finally, data are presented that show that the LIMD1 family member proteins Ajuba and WTIP all bind specifically to VHL but differentially to PHDs 1, 2 and 3 and thus these three LIM domain containing proteins represent a new group of hypoxic regulators.616.07QU BiochemistryUniversity of Nottinghamhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.523477http://eprints.nottingham.ac.uk/11280/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 616.07
QU Biochemistry
spellingShingle 616.07
QU Biochemistry
Webb, Thomas M.
The tumour suppressor protein LIMD1 is a novel regulator of HIF1 and the hypoxic response
description There are three prolyl hydroxylases (PHD1, 2 and 3) that regulate the hypoxia-inducible factors (HIFs), the master transcriptional regulators that respond to changes in intracellular O2 tension. In high O2 tension (normoxia) the PHDs hydroxylate HIFα subunits on 2 conserved proline residues inducing binding of the von-Hippel-Lindau (VHL) tumour suppressor, the recognition component of a multi-protein ubiquitin-ligase complex, initiating HIFα ubiquitylation and degradation by the 26S proteasome. However, it is not known whether PHDs and VHL act separately to exert their enzymatic activities on HIFα or as a multi-protein complex. In this thesis, data are presented that shows that the tumour suppressor protein LIMD1 acts as a molecular scaffold simultaneously binding the PHDs and pVHL into a normoxic protein complex (normoxiplex), increasing their physical proximity in order to enable efficient and rapid sequential modifications and thus degradation of HIF1α. Data are presented which indicates that increased LIMD1 expression down regulates HIF transcriptional activity, by promoting HIF1α degradation via the oxygen dependent degradation domain in a manner dependent on hydroxylase and 26S proteasome activities. However, degradation of this domain is not wholly dependent on the well characterised proline residues subject to hydroxylation, suggesting that LIMD1 may alter proline hydroxylation specificity or modulate HIF via a different mechanism. Furthermore, endogenous depletion of LIMD1 results in the converse, leading to HIF1α stabilisation and accumulation, enhancing HIF transcriptional activity. Moreover, Limd1-/- MEFs show increased HIF transcriptional activity. One mechanism by which this is achieved involves the binding of PHD2 within the N-terminal portion of LIMD1 while allowing concurrent binding of VHL to the C-terminal zinc-finger LIM domains. However, the LIMD1 mediated mechanism regulating HIF1α independently of proline residues 402 and 564 is still unclear. Finally, data are presented that show that the LIMD1 family member proteins Ajuba and WTIP all bind specifically to VHL but differentially to PHDs 1, 2 and 3 and thus these three LIM domain containing proteins represent a new group of hypoxic regulators.
author Webb, Thomas M.
author_facet Webb, Thomas M.
author_sort Webb, Thomas M.
title The tumour suppressor protein LIMD1 is a novel regulator of HIF1 and the hypoxic response
title_short The tumour suppressor protein LIMD1 is a novel regulator of HIF1 and the hypoxic response
title_full The tumour suppressor protein LIMD1 is a novel regulator of HIF1 and the hypoxic response
title_fullStr The tumour suppressor protein LIMD1 is a novel regulator of HIF1 and the hypoxic response
title_full_unstemmed The tumour suppressor protein LIMD1 is a novel regulator of HIF1 and the hypoxic response
title_sort tumour suppressor protein limd1 is a novel regulator of hif1 and the hypoxic response
publisher University of Nottingham
publishDate 2010
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.523477
work_keys_str_mv AT webbthomasm thetumoursuppressorproteinlimd1isanovelregulatorofhif1andthehypoxicresponse
AT webbthomasm tumoursuppressorproteinlimd1isanovelregulatorofhif1andthehypoxicresponse
_version_ 1718386061848084480